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Primary cultures of human epidermal cells produce 
plasminogen activator (P A) as demonstrated by the abil-
ity of conditioned medium or cell lysates to hydrolyze 
fibrin in the presence of plasminogen, and to cleave 
[l 25l)plasminogen to characteristic fragments . The ma-
jor molecular species of P A in human epidermal cells 
was inhibited by diisopropylfluorophosphate and comi-
grated in sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis with the high molecular weight band of 
human urokinase (Mr 55,000) . Production of P A by 
human epidermal cells was inhibited by cycloheximide, 
stimulated by colchicine, and not affected by cytochal-
asin B or the tumor promoter 12-0-tetradecanoyl-phor-
bol-13-acetate. Both cholera toxin and epidermal 
growth factor stimulated P A activity in human epider-
mal cells, and P A activity was maximal at concentra-
tions that best support in vitro growth of human epider-
mal cells. Examination of individual cells indicated that 
at least 15% of cells within a culture produced detectable 
amounts of P A. 
P lasmi nogen activators (P A) are serine proteinases which 
catalyze t he conversion of plasminogen to plasmin. Recently 
t he role of plasminogen activators in the regu lation of localized 
proteolysis within t he microenvironment of cells has received 
much attent ion . A wide variety of normal vertebrate adult and 
embryonic cells produce P A under defined circumstances and 
this production is highly regulated (for review see [1- 3]). In-
cluded among these cells are macrophages [4,5], granulocytes 
[6], ovarian granulosa cells [7], fibroblasts [8- 12], t rophoblasts 
[13], endothelial cells (14], and squamous epithelium [15- 17]. 
T hese reports have suggested that the highly regulated produc-
tion of P A is of crit ical importance in t issue remodeling and 
cell migration. While litt le is known about P A in human 
epidermal cells, recent reports have implicated PA as having 
an important role in epidermal differentiation and integrity of 
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t he epidermis (17- 20]. Studies from our laboratory indicate 
that PA activity in psoriatic epidermis correlates with disease 
activity [21,22] and that human epidermal cells in culture can 
be induced to increase PA synthesis and secretion when incu-
bated with anti-cell -surface autoantibody from patients with 
pemphigus, an autoimmune blistering skin disease [20]. The 
data presented here describe P A metabolism in human epider-
mal cell cultures and provide a framework for the study of P A 
as a regu latory molecule in human epidermis. 
MATERIALS AND METHODS 
Materials 
Chem icals and supplies were obtained from t he following sources: 
Hanks' balanced salt solu t ion, feta l calf serum; dog serum, and a nt i-
biotic/antimycotic from GIBCO, Grand Island, New York; Dulbecco's 
modified Eagle's medium from Band B Research, Balt imore, Maryland; 
t rypsin , mitomycin C, bovine fibrinogen, Triton X-100, EDTA, colchi-
cine, cytochalas in B, glycerol, and aprotinin from Sigma, St. Louis, 
Missouri ; hydrocortisone and cycloheximide from Calbiochem-Behring, 
La Jolla, California; cholera toxin and Tris from Schwartz-Ma nn, 
Orangeburg, New York; Coomassie B lue, bromphenol blue dith iothrei-
tol, and sodium dodecyl sulfate from Bio Rad Laboratories, Richmond, 
California; Jysine-Sepharose and Sephadex G-25 from P harmacia , P is-
cataway, New J ersey; cluster 6 culture dishes a nd 60-mm culture dishes 
from Costar, Cambridge, Massachusetts; Linbro mult i-well plates from 
Flow Labs, McLean, Virginia; microfuge tubes from Walter Sarstedt, 
Princeton, New Jersey; epidermal growth factor from Collaborative 
Research, Waltham, Massachusetts; urokinase reference standard from 
Leo Pharmaceutical Industries, Ballerup, Denmark; SeaPlaque agarose 
from FMC Corp., Rockland, Ma ine; TPA from Consolidated Midlands, 
Brewster, New York; chloroglycouril from Pierce Chemical Co., Rock-
ford, Illinois; 1251 from New England Nuclear, Boston, Massachusetts; 
Kodak XO-mat fi lm from Eastman-Kodak, Rochester, New York; and 
nonfat dry milk powder from Kroger Co. 
Epidermal Cell Cultures 
Human epidermal cells from newborn foreskins were cultured using 
a modification of the techn ique ofRheinwald a nd Green [23]. Foreskins 
were obtained within 3 h of circumcision and incubated in 0.25 % trypsin 
in Ha nks' balanced salt solution and incubated at 4 OC for 18- 24 h. T he 
epidermis was then easily removed from t he dermis and teased wit h 
forceps to obtain a cell suspension. Cells were plated in to t he we lls of 
Costar Cluster 6 t issue culture d-ishes (1-2 X 105 cells per 8-cm2 well) 
that had been seeded with mitomycin C-treated (15 IJ.g/ml, 2 h, 37oC) 
mouse 3T3 fibroblasts (CCL 92, American Type Cul ture Collection, 
Rockvi lle, Maryland). Epidermal cells were grown in Dulbecco's mod-
ified Eagle's medium (DMEM) supplemented with fetal calf serum 
(FCS) to a tina! concent ration of 20%, 20 ng/ml epiderma l growth 
factor , 0.4 11g/ml hydrocort isone, 10- 10 M cholera toxin, 100 units/ml 
penicillin, 100 11g/ml streptomycin, and 0.25 11g/m l fungizone (anti-
biotic/a nt imycotic). Cul tures were con!1uent within 3- 5 weeks. All 
experiments were performed on primary cell cultures which had reached 
confluence a nd were wi t hout remaining 3T 3 fibroblasts. 
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Harvest of Conditioned Medium and Cell Lysa.tes 
After reaching con!1uence the cells were incubated at 37oC overnight 
with DMEM containing 20% FCS a nd no other addit ives. The cul tures 
were t hen incubated at 37oC for 24 h with DMEM (1 ml/ well ). Condi -
tioned medium was harvested, cent rifuged at 6500 g for 5 min, a nd 
assayed for extracellula r PA activity using the fibrin plate method 
described below. The cells were washed 3 times with phosphate-buffered 
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saline (PBS), pH 7.3, and t reated wi t h 0.5% Tri ton X-100 in 0.01 M 
Tris-H CI, pH 7.8, fo r 5 min at 4•c (1 ml / well ). T he wells were scraped 
wi t h a rubber policeman and t he contents t ra nsferred to a 1.5-ml 
microfuge tube and cent ri fuged at 6500 g for 5 min . The supernatant 
(celllystate) was assayed to determine cell -associated PA activity. The 
wells used in a single experiment conta ined cells originating from the 
same foreskin . Preliminary experiments documented that, at conllu-
ence, the cell number in di fferent wells from a single foreskin varied 
by < 15% (data not shown) . Cell numbers were not rout inely deter-
mined in each well because it was desirable to obta in cell lysates from 
each well. Determination of ce ll numbers would have required t rypsin-
ization which would have alte red cell viabili ty and int roduced t ryps in-
re lated art ifacts. 
A ssays for Plasminogen Activator 
Hydrolysis of [ 125/}plasminogen: Conditioned medium collected from 
cultured huma n epidermal cells was tested directly for its abili ty to 
hydrolyse [125l]plasminogen to t he 2 cha racteristic polypept ide chains 
detected by sodium dodecyl sul fate-polyacrylamide gel electrophoresis 
(SDS-PAGE ) and auto radiography [24 ]. Human plasminogen was pur-
ified according to Deutsch and Mertz [25] using 2 cycles of affini ty 
chromatography on lys ine-Sepharose and iodinated using chlorogly-
couril [26]. Free 1251 was removed using minicolumns of Sephadex G-
25 [27]. The specific activi ty of [125l]plasminogen obtained was 1.3 x 
106 cpm/ J.Lg protein. [125l]Piasminogen (0.4 J.Lg) was incubated at 37•c 
for 30 min wit h aprotinin (600 kallikrein inhibito ry uni ts/ml) and 
varying amounts of conditioned medium in a total volume of 60 J.LI 0.1% 
Tri ton X-100 in 0.1 M Tris-HCI, pH 8. 1. 
Concent rated SDS-PAGE sample buffer (30 J.LI ) was added to give a 
fin al concentration of 2.3 % SDS, 10% glycerol, 0.005% bromphenol 
blue, a nd 0.1 M di thiothreitol. Samples were boiled for 2 min and 45 J.LI 
applied to each lane of a polyacrylamide slab gel (12.5% running 
gel, 5% stacking ge l) a nd electrophoresed using t he buffe r system of 
Laemmli [28]. Gels were stained wit h Coomasie Blue, destained, dried, 
a nd autoradiographed using Kodak XO-mat film and developed fo llow-
ing 45 min exposure. 
Fibrin. plate assay: PA activi ty was quant itated using mul ti-well 
cul ture dishes coated wit h [ 125l]fi brin according to Strickland a nd Beers 
[13]. Each well (surface area 2 cm2 ) was coated wit h 25 J.Lg [1251] -
fibrinogen (4000 cpm/ J.L g) [29,30] . Conversion of fibrinogen to fibrin 
was accomplished by a 2-h incubation at 37•c with DMEM supple-
mented wit h 5% plasminogen-depleted fetal bovine serum . The reaction 
mixture contained 50 J.LI of samples (either cell lysates or conditioned 
medium) and 1.2 J.Lg of dog plasminogen, or 1.2- 2.4 J.Lg human plasmin-
ogen [25 ] in a total volume of 300 J.LI of 0.1 M Tris- HCI, pH 8.1. The 
dishes were incubated for 60 min at 37•c afte r which t he supernatant 
was collected and the release of 1251-labeled pept ides from t he [1251] -
fibrin was quant itated using an LKB Model 1270 RackGa mma II 
gamma coun te r (LKB, Turku, Finla nd). 
P A activi ty in conditioned medium a nd celllysates was compared to 
the activity of a standard preparation of human urokinase measured 
on the same day. In each assay a standard curve of PA activi ty was 
generated over a range of 1.6- 25 milli Ploug units of urokinase activity. 
All samples were diluted to fall wit hin t he linear range of t he standa rd 
curve. All assays were performed in duplicate and duplicates varied by 
~ 10%. The PA activity in each sample was computed from t he standard 
curve using t he RackGamma RIA data reduction system. 
Since the number of cells in conlluent wells originating from t he 
same foreskin differed by~ 15%, the PA ac tivi ty in the samples was 
expressed as uni ts of ac tivity per well. Extracellula r activi ty was 
expressed as milli Ploug units (mU) per ml condi t ioned medium col-
lected from 1 well of a Costar Cluster 6 plate (surface a rea 8 cm2) . Cell -
associated PA activity is expressed as milli Ploug uni ts per ml cell 
lysate extrac ted from 1 well. 
Casein./ agarose plaque assay: Production of plasminogen activator by 
cul tured huma n epidermal cells was detected at t he single cell level 
using a modification of t he casein -aga rose overlay technique of Gold-
berg '[31] . Cultured human epidermal cells were t rypsinized (0.25 % 
t rypsin in 0.02% EDTA, 5 min), washed 3 t imes wit h DMEM, and 
counted. The cells were added to tubes in a 37•c water bath. The tubes 
contained DMEM, a final concent ration of 0.9% Sea Plaque agarose, 
1.6% commercial nonfat dried milk powder, and various concent rations 
of human plasminogen (0- 100 J.Lg/ml) . Aliquots (350 J.Ll) conta ining 
approx imate ly 2500 cells were t ransferred to each 60-mm prewet cul ture 
dish. Agar was allowed to harden and the plates were incubated at 37•c 
for 2-48 h in a moist chamber. Lytic zones were counted under dark -
field illumination using a magnifying glass and were also observed by 
phase contrast microscopy. 
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E lectrophoretic A nal.ysis of Plasminogen Activator 
The electrophoretic analysis of epiderma l cell PA was perfo rmed by 
t he method of Vetterlein eta! [32]. Condit ioned medium was collected 
from cultured epiderma l cells. The samples were then dia lyzed to a 
buffer of 0.06 M Tris, pH 6.8, containing 2.3 % SDS, 10% glycerol, and 
0.005% bromphenol blue. E lectrophoresis was carried out in slab gels 
using 0.1 % SDS, a 12.5% polyacrylamide running gel, and a 5% 
polyacrylamide stacking gel, a nd t he Laemmli buffer system [28,33]. 
The gel was removed from t he glass plates, agitated in 2.5% Tri ton X-
100 in 0.1 M Tris-H CI, pH 8. 1, at 22 · c for 1 h; each lane was sliced 
into 2-mm slices. Each gel s lice was assayed for P A activity in t he 
[ 125l]fibrin plate assay described above. 
RESULTS 
Hydrolysis of Plasminogen by Conditioned Medium from 
Human Epidermal Cell Cultures 
T o determine whether PA was produced and secreted by 
cul tured human epidermal cells, conditioned medium was col-
lected from cultures of human epidermal cells and incubated 
with [12r.I]plasminogen. SDS-PAGE confirmed t he ability of 
the conditioned medium to hydrolyze plasminogen (Fig 1, lane 
A ) to its characteristic polypeptide components of M, 64,000 
and 25,000 (Fig 1, lanes B and C) [1,24]. In an overdeveloped 
autoradiograph, t he 25,000 dalton band was more clearly seen 
in lanes B and C. The cleavage products were indistinguishable 
from t hose obtained following incubation of [125l]plasminogen 
with urokinase (Fig 1, lane D). 
Quantitation of Epidermal Cell PA by the Fibrin Plate Assay 
The t ime and PA dose dependence of t he [125l]fibrinolysis 
assay was determined using condit ioned medium from cultured 
human epidermal cells as a source of PA (Fig 2) . After a short 
lag t ime, hydrolysis of [125I]fibrin was linear from 30-60 min 
(Fig 2). Subsequent assays were incubated for a maximum of 
60 min. Production of [12, I]fibrin pept ides was dependent upon 
the amount of condit ioned medium added and was linear over 
a range of act ivit ies. 
A B c D 
94K-
61 K-
31K-
FIG 1. S DS- P AGE a nalys is of t he hydrolys is of [125l] plasminogen 
by conditioned medium from cul tured human epidermal cells. (121'1] -
Piasminogen (0.4 J.Lg) was incubated for 30 min at 37•c alone (A) or 
wit h 10 J.Ll condi t ioned medium (B) , 20 J.LI conditioned medium (C) or 
human urokinase (D ). 
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E lectrophoretic Analysis of PA from Cultured Human 
Epidermal Cells 
Two major types of human P A are distinguished both bio-
chemically and immunologically. The "urokinase type" has a 
M, of 52,000-55,000 whereas the "tissue type" has a M, of 
68,000-74,000 [11,32]. Since PAis not irreversibly inactivated 
by SDS [6], it is possible to analyze PA after electrophoresis in 
SDS-polyacrylamide gels. The electrophoretic profile of enzy-
matic activity indicated that the major peak of P A activity 
secreted by unstimulated, cultured human epidermal cells was 
of M, 55,000 (Fig 3). A trailing of enzymatic activity was seen 
at higher M,s. The small peak of activity at 36,000 has been 
reported by others [32]. 
When conditioned medium from cultured epidermal cells was 
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FIG 2. Hydrolysis of (125I]fibrin by conditioned medium from human 
epidermal cell cultures. 
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FIG 3. Electrophoretic analysis of PA secreted by cultured human 
epidermal cells. Conditioned medium containing 1.5-2.5 milli Ploug 
units of urokinase equivalent activity was dialyzed against SDS-PAGE 
sample buffer and applied to SDS polyacrylamide gels. Following 
electrophoresis, the gel was incubated in 2.5% Triton X-100 to remove 
SDS and sliced into 2-mm slices Each slice was assayed for PA activity 
in t he (' 25l]fibrin plate assay. 
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FIG 4. Inhibition of epidermal PA activity by cycloheximide. Cul-
tured human epidermal cells were incubated for 24 h in serum-free 
medium containing cycloheximide. Conditioned medium (0) and cell 
lysates (e) were harvested as described and PA activity quantitated 
using the [125l]fibrin plate assay. 
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FIG 5. Effects of colchicine on epidermal PA. Cultured human epi-
dermal cells were incubated with colchicine for 24 h. Conditioned 
medium and cell lysates were assayed for PA activity using the (1251]-
flbrin plate assay. The arrowheads indicate the values in the absence 
of colchicine. 
incubated at 37oC for 2 h with 8 mM diisopropylfluorophosphate 
(DFP), PA activity was diminished by approximately 50% as 
detected by the [125l)fibrin plate assay. Less than 10% of the 
P A activity remained after incubation of conditioned medium 
with 8 mM DFP for 18 hat 22oC (data not shown). 
Protein Synthesis Requirement for PA Production by 
Epidermal Cells 
Levels of both extracellular and cell-associated P A were 
partially inhibited by cycloheximide at 10 !Lg/ml, a concentra-
tion which inhibited incorporation of (35S]methionine into pro-
tein by 80% in epidermal cells (Fig 4). 
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Stimulation of Epidermal Cell PA by Colchicine 
Vassalli et a!, using thioglycollate-stimulated mouse macro-
phages, reported inhibition of P A activity by colchicine and 
vinblastine, agents which interact with microtubules. Incuba-
tion of human epidermal cells with colchicine gave results 
dramatically different from those obtained by Vassalli eta! [34) 
with stimulated mouse macrophages (Fig 5). At concentrations 
of 5 X 10- 7 to 5 X 10-6 M both extracellular and cell-associated 
PA activity were increased. 
Incubation of human epidermal cells with 5 X 10- 7 to 5 X 
10- 5 M cytochalasin B did not affect extracellular or cell-
associated PA activity (data not shown). 
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FIG 6. Stimulation of extracellular plasminogen activator levels by 
epidermal growth factor and cholera toxin . The arrow indicates the 
value in the absence of CT. 
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Effect of the Tumor Promoter 12-0-Tetradecanoyl-phorbol-13-
acetate (TPA) on Epidermal PA 
Stimulation of PA production by TPA in a variety of cultured 
cell types has been reported [10,35,36); however the stimulatory 
effect is not universal. Brown [16) reported that while TPA (5 
x 10- 7 M) increased synthesis of DNA in cultured mouse 
epidermal cells, the PA activity was not affected. Cultured 
human epidermal cells were incubated for 6 or 12 h with 50 or 
100 ng/ml TP A. Conditioned medium and cell lysates were 
harvested and tested for PA activity in the fibrin plate assay. 
After 6-h incubation there was no difference in extracellular or 
cell-associated PA activity of cells incubated with 50 or 100 ng/ 
ml TP A over that of controls without TP A. By 24 h the 
extracellular P A activity was slightly higher with cells incu-
bated with 50 or 100 ng/ ml TP A. In 4 different experiments 
these levels were never mor:.e· than 160% of controls (data not 
shown). 
Stimulation of Epidermal Cell PA by Cholera Toxin (CT) and 
Epidermal Growth Factor (EGF) 
Epidermal cell cultures employed in these experiments were 
routinely maintained in the presence of EGF from mouse 
submaxillary glands [37] and CT [38]. The effects of these 
agents on P A were tested in cells that had been removed from 
EGF and CT for at least 24 h prior to a 24-h serum-free 
incubation for collection of conditioned medium. Conditioned 
medium and cell lysates were then tested for P A activity using 
the fibrin plate assay. As shown in Fig 6, both CT and EGF 
stimulated extracellular PA in human epidermal cell cultures. 
Interestingly, the highest levels of PA were found in cells 
incubated with these agents at the concentrations reported as 
optimal for the growth of human epidermal cells (37,38) . Sim-
ilar results were obtained in cell lysates (data not shown). 
There was no detectable increase in cell number during the 
course of these studies. 
FIG 7. PA production by si ngle epi-
dermal cells. Cultured human epidermal 
cells were suspended in agar containing 
milk powder in t he presence or absence 
of plasminogen and incubated at 37•c 
for 3 h. Panel A shows a t ransparent 
lytic zone around a cell indicating secre-
tion of PA and hydrolysis of casein in 
the presence of 10 1-<g/ml plasminogen. 
The arrows point to cells which did not 
secrete a detectable amount of P A. 
Panels B, C, and D indicate the plasmin-
ogen dependence of the hydrolysis of 
casein: (B) 0 1-'g/ml plasminogen; (C) 10 
1-'g/ ml plasminogen; (D) 100 1-'g/ml plas-
minogen. 
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Production of PA by Individual Cultured Human Epidermal 
Cells 
Cultured human epidermal cells were examined as single 
cells. Cells were suspended in agar containing milk powder as 
a source of casein substrate, in the presence or absence of 
plasminogen (0- 100 J.Lg/ml). The presence of PA was indicated 
by the formation of a transparent lytic zone around a cell (Fig 
7A) caused by hydrolysis of casein. Production of lytic plaques 
was dependent upon plasminogen (Fig 8B,C,D). This technique 
did not allow determination of the actual percentage of cells 
producing PA because after 12- 18 h the lytic zones began to 
merge; however after 6 h, when distinct zones were visible, at 
least 15% of the cells were producing detectable amounts of 
PA. Greater than 95% of t he cells were viable as judged by 
trypan blue exclusion. 
DISCUSSION 
PA is synthesized in a highly regulated fashion by a wide 
variety of cell types. It has become increasingly apparent that 
in addition to its role in the fibrinolytic cascade, PA is impor-
tant for regulation of extracellular proteolysis affecting many 
aspects of cell behavior. Myhre-Jensen and Astrup [39] postu-
lated in 1971 that PA might function in terminal differentiation 
and enucleation of squamous epithelium; however the produc-
tion of P A by epidermal cells has until recently not received 
much attention. With the development of culture systems for 
the in vitro propagation of both mouse and human epidermal 
cells it has become possible to investigate the production and 
regulation of molecules such as P A by epidermal keratinocytes. 
Green reported that plasminogen was necessary for the destruc-
tion of nuclei during epidermal differentiation [18], indicating 
a possible regulatory role for P A in epidermal differentiation. 
Isseroff et al [ 19] reported that production of P A by cu ltured 
mouse epic!ermal cell lines was correlated with differentiation. 
Brown [16] and Chambers et al [17] have shown that PA 
production in cultured, nontransformed mouse epidermal cells 
correlates with epidermal differentiation and that regulation of 
P A production in mouse epidermal cells may differ from that 
reported in other cell types. We have reported that stimulation 
of PA following binding of anti-cell-surface autoantibody is 
responsible, through activation of plasmin, for loss of epidermal 
cohesion in the blistering disease pemphigus [20]. We have also 
found that levels of PA activity correlate with disease activity 
in psoriasis [21,22]. 
We report here that PAis produced and secreted by human 
epidermal cells in culture and that the predominate molecular 
species is of M, 55,000. Unlike PA production in mouse mac-
rophages [34], PA production in human epidermal cells was 
stimulated by colchicine; cytochalasin had no effect on P A in 
human epidermal cells, in agreement with its reported lack of 
effect on PA of mouse macrophages [34]. PA production by a 
number of cell types is stimulated by the tumor promoter TPA. 
TP A did not affect P A production in cultured human epidermal 
cells. This is in agreement with the lack of TPA-induced 
stimulation of P A in mouse epidermal cells reported by Brown. 
CT and EGF stimulated the production of PA and the stimu-
lation was maximal at concentrations which best support the 
in vitro growth of these cells. Brown [16] found that EGF did 
not stimulate PA production in mouse epidermal cells. The 
human epidermal cells used here were grown in 20 ng/ml EGF 
and 10- •o M CT. It is possible that the culture conditions have 
selected for the growth of a population of cells in which protein 
synthesis is greatest under those conditions and the stimulatory 
effect on P A is nonspecific. Experiments are under way to 
clarify this point. The data reported here provide a framework 
for the study of P A as a regulatory molecule in normal human 
epidermis and for further study of P A in epidermal disease 
states. 
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Structural Integration of Skin Equivalents Grafted to Lewis and 
Sprague-Dawley Rats 
BARBARA E. HULL, PH.D., STEPHANIE E. SHER, PH .D., SEYMOUR ROSEN, M.D., DIANE CHURCH, B.A., AND 
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Biology Department (BEH, SES, DC, EB), Massachusetts Institute of Technology, Cambridge, and Pathology Department (SR), Beth Israel 
Hospital, Harvard Medical School, Charles A. Dana Research Institute, Boston, Massachusetts, U.S.A. 
Bilayered skin equivalents, composed of a sheet of 
epidermal cells overlying a collagen lattice populated 
with fibroblasts, quickly become structurally integrated 
with the surrounding host skin after grafting to Lewis 
rats. Three days after transplantation, the skin equiva-
lent lies on a bed of host granulation tissue and is loosely 
attached to the adjoining host dermis. Blood vessels 
begin to invade the collagen lattice by 5 days after 
grafting. By the 7th day a fully keratinized, hyper-
trophic epidermis covers the surface of the graft and 
blood vessels penetrate the lattice to the base of the 
epidermis. Vascularization of the graft is accompanied 
by activation and proliferation of the fibroblasts and by 
a condensation of the collagen matrix. During the 2nd 
week after grafting, the collagen fibrils become or-
ganized into thin fibers that show a basketweave pattern 
of birefringence when examined using polarized light. 
By 1 month the structure of the skin equivalent has 
become stabilized. The fibroblasts now resemble the 
quiescent fibrocytes of normal, resting dermis and the 
epidermis remains moderately hypertrophic. One to two 
years after grafting to Sprague-Dawley rats, the skin 
equivalents do not appear hypertrophic. The graft lacks 
secondary derivatives such as hair follicles and sweat 
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glands, presumably because the stem cells are lost during 
the isolation of the epidermal cells. Grafts that are pre-
pared using epidermal cells overlying a collagen gel 
without fibroblasts give rise to raised, linear scars 
within 2 weeks. 
Since t he epidermis plays a vital role in protecting the body 
from dehydration and infection, many laboratories concerned 
with t he development of a skin replacement have focused on 
the preparation of epidermal sheets suitable for grafting. Epi-
dermal sheets have been cultured directly on plastic dishes 
[1], on layers of lethally irradiated fibroblasts [2], or on pieces 
of nonviable, porcine dermis [3,4]. Although epidermal sheets 
quickly attach to t he graft bed and provide a temporary covering 
for the wound, a thin layer of dermis must be present eit her in 
the graft bed or underlying the epidermis in order to inhibit 
wound contraction [5,6]. A nonliving, synthetic substitute [7,8] 
could be readily available in an emergency but the cross-linked 
collagen must be degraded and replaced by invading host cells. 
Efforts in our laboratory have therefore concentrated on the 
development of a living, bilayered, skin substitute, called a 
"skin equivalent." 
We have synthesized a living dermal equivalent in vitro by 
combining fibroblasts with collagen, serum, and tissue culture 
medium [9]. The collagen gels quickly at neutral pH and t he 
fibrobla_sts actively contract the network of collagen fibrils, 
expressmg flllld, to form a t issue-like lattice with coherence 
and tensile strength [10]. A bilayered skin equivalent is then 
formed by adding a suspension of epidermal cells to t he surface 
of the lattice. T he epidermal cells attach, proliferate, and 
differentiate to form a multilayered epidermis. Skin equivalents 
